Predicting Prognosis in Idiopathic Pulmonary Fibrosis - Licensing opportunity from University College Dublin - April 2014 front page preview

Predicting Prognosis in Idiopathic Pulmonary Fibrosis - Licensing opportunity from University College Dublin - April 2014

The TLR3 L412F polymorphism is a potential biomarker of aggressive disease and early mortality in IPF patients. This sub-group of IPF patients with the TRL3 polymorphism could benefit from therapy with INF-beta. UCD r...

pdf 1.5MB

Prostate Cancer Biomarkers: MRM assay - Licensing opportunity from University College Dublin _ April 2014 front page preview

Prostate Cancer Biomarkers: MRM assay - Licensing opportunity from University College Dublin _ April 2014

Multiplexed screening or monitoring of prostate cancer biomarkers to determine Gleason stage and ECE. MRM based assay for fast, sensitive quantification of protein biomarkers in large numbers of serum samples. Existing...

pdf 1.3MB

Isolation and Detection of the Bowman Birk Inhibitor (BBI) - Licensing opportunity from University College Dublin - April 2014 front page preview

Isolation and Detection of the Bowman Birk Inhibitor (BBI) - Licensing opportunity from University College Dublin - April 2014

Use of novel peptide probes for the selective detection and purification of the BBI, a soybean derived bioactive. This opportunity offers a novel one step affinity separation method for the isolation of BBI as an altern...

pdf 229.4KB

Novel diagnostic test for postpartum infections in cattle - Licensing opportunity from University College Dublin - April 2014 front page preview

Novel diagnostic test for postpartum infections in cattle - Licensing opportunity from University College Dublin - April 2014

Technology currently being developed within UCD aims to provide an innovative diagnostic tool for the early detection of postpartum infections in livestock. It is hoped that with further research, this tool will have a p...

pdf 202.5KB

Epigenetic Therapy for Hypertrophic Cardiomyopathy - Licensing opportunity from University College Dublin - April 2014 front page preview

Epigenetic Therapy for Hypertrophic Cardiomyopathy - Licensing opportunity from University College Dublin - April 2014

UCD researchers have shown that the DNA methylation inhibitor 5-azacitidine (5-aza) improves cardiac function, including hypertrophy and diastology, in a murine animal model (SHR, spontaneously hypertensive rat, model) a...

pdf 1.4MB